Author： Latini Jerilyn M Giannantoni Antonella
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.7, 2011-05, pp. : 1017-1027
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The pharmacotherapy of overactive bladder
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. :
Access to resources
Recommend
Pediatric Overactive Bladder Syndrome: Pathophysiology and Management
Pediatric Drugs, Vol. 9, Iss. 6, 2007-01 ,pp. :
By Sahai Arun Khan Mohammed Shamim Arya Manit John Jason Singh Rajinder Patel Hitendra RH
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. :
Transdermal Oxybutynin: For Overactive Bladder
By Bang L.M. Easthope S.E. Perry C.M.
Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. :
Solifenacin in Overactive Bladder Syndrome
Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. :